Dr Mark Millan

  • Visiting Professor (School of Psychology & Neuroscience)

email: Mark.Millan@glasgow.ac.uk

Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, Paris - France

Import to contacts

Publications

List by: Type | Date

Jump to: 2023 | 2022 | 2021 | 2017 | 2012
Number of items: 8.

2023

Solmi, M. et al. (2023) Validation of the collaborative outcomes study on health and functioning during infection times (COH-FIT) questionnaire for adults. Journal of Affective Disorders, 326, pp. 249-261. (doi: 10.1016/j.jad.2022.12.022) (PMID:36586617) (PMCID:PMC9794522)

2022

Saarinen, M., Mantas, I., Flais, I., Ågren, R., Sahlholm, K., Millan, M. J. and Svenningsson, P. (2022) TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT. Neuropsychopharmacology, 47(13), pp. 2319-2329. (doi: 10.1038/s41386-022-01421-2) (PMID:36100653)

Hanbouch, L. et al. (2022) Specific mutations in the cholesterol-binding site of APP alter its processing and favor the production of shorter, less toxic Aβ peptides. Molecular Neurobiology, 59(11), pp. 7056-7073. (doi: 10.1007/s12035-022-03025-9) (PMID:36076005) (PMCID:PMC9525381)

Lazar, A.-N., Hanbouch, L., Boussicaut, L., Fourmaux, B., Daira, P., Millan, M. J., Bernoud-Hubac, N. and Potier, M.-C. (2022) Lipid dys-homeostasis contributes to APOE4-associated AD pathology. Cells, 11(22), 3616. (doi: 10.3390/cells11223616) (PMID:36429044) (PMCID:PMC9688773)

Millan, M. J. (2022) Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action. Therapeutic Advances in Psychopharmacology, 12, p. 20451253221105128. (doi: 10.1177/20451253221105128) (PMID:35795687) (PMCID:PMC9251978)

2021

Mantas, I., Millan, M. J., Di Cara, B., Groenink, L., Veiga, S., Cistarelli, L., Brocco, M., Bertrand, M., Svenningsson, P. and Zhang, X. (2021) Trace Amine-Associated Receptor 1 contributes to diverse functional actions of o-phenyl-iodotyramine in mice but not to the effects of monoamine-based antidepressants. International Journal of Molecular Sciences, 22(16), 8907. (doi: 10.3390/ijms22168907)

2017

Marsango, S., Caltabiano, G., Jiménez-Rosés, M., Millan, M. J., Pediani, J. D. , Ward, R. J. and Milligan, G. (2017) A molecular basis for selective antagonist destabilization of dopamine D3 receptor quaternary organization. Scientific Reports, 7, 2134. (doi: 10.1038/s41598-017-02249-3) (PMID:28522847) (PMCID:PMC5437050)

2012

Pou, C., Mannoury la Cour, C., Stoddart, L.A., Millan, M.J. and Milligan, G. (2012) Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface. Journal of Biological Chemistry, 287(12), pp. 8864-8878. (doi: 10.1074/jbc.M111.326678)

This list was generated on Sun Jun 23 23:10:12 2024 BST.
Jump to: Articles
Number of items: 8.

Articles

Solmi, M. et al. (2023) Validation of the collaborative outcomes study on health and functioning during infection times (COH-FIT) questionnaire for adults. Journal of Affective Disorders, 326, pp. 249-261. (doi: 10.1016/j.jad.2022.12.022) (PMID:36586617) (PMCID:PMC9794522)

Saarinen, M., Mantas, I., Flais, I., Ågren, R., Sahlholm, K., Millan, M. J. and Svenningsson, P. (2022) TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT. Neuropsychopharmacology, 47(13), pp. 2319-2329. (doi: 10.1038/s41386-022-01421-2) (PMID:36100653)

Hanbouch, L. et al. (2022) Specific mutations in the cholesterol-binding site of APP alter its processing and favor the production of shorter, less toxic Aβ peptides. Molecular Neurobiology, 59(11), pp. 7056-7073. (doi: 10.1007/s12035-022-03025-9) (PMID:36076005) (PMCID:PMC9525381)

Lazar, A.-N., Hanbouch, L., Boussicaut, L., Fourmaux, B., Daira, P., Millan, M. J., Bernoud-Hubac, N. and Potier, M.-C. (2022) Lipid dys-homeostasis contributes to APOE4-associated AD pathology. Cells, 11(22), 3616. (doi: 10.3390/cells11223616) (PMID:36429044) (PMCID:PMC9688773)

Millan, M. J. (2022) Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action. Therapeutic Advances in Psychopharmacology, 12, p. 20451253221105128. (doi: 10.1177/20451253221105128) (PMID:35795687) (PMCID:PMC9251978)

Mantas, I., Millan, M. J., Di Cara, B., Groenink, L., Veiga, S., Cistarelli, L., Brocco, M., Bertrand, M., Svenningsson, P. and Zhang, X. (2021) Trace Amine-Associated Receptor 1 contributes to diverse functional actions of o-phenyl-iodotyramine in mice but not to the effects of monoamine-based antidepressants. International Journal of Molecular Sciences, 22(16), 8907. (doi: 10.3390/ijms22168907)

Marsango, S., Caltabiano, G., Jiménez-Rosés, M., Millan, M. J., Pediani, J. D. , Ward, R. J. and Milligan, G. (2017) A molecular basis for selective antagonist destabilization of dopamine D3 receptor quaternary organization. Scientific Reports, 7, 2134. (doi: 10.1038/s41598-017-02249-3) (PMID:28522847) (PMCID:PMC5437050)

Pou, C., Mannoury la Cour, C., Stoddart, L.A., Millan, M.J. and Milligan, G. (2012) Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface. Journal of Biological Chemistry, 287(12), pp. 8864-8878. (doi: 10.1074/jbc.M111.326678)

This list was generated on Sun Jun 23 23:10:12 2024 BST.